189
Views
0
CrossRef citations to date
0
Altmetric
Case Report

A typical anterior retinoblastoma: diagnosis by aqueous humor cell-free DNA analysis

, , , , , & show all
Pages 862-865 | Received 18 Oct 2022, Accepted 22 Oct 2022, Published online: 03 Nov 2022
 

ABSTRACT

Background

Aqueous humor from eyes with active retinoblastoma contains tumor-derived cell-free DNA.

Materials and Methods

Single retrospective case report.

Results

A 13-year-old girl with acute right eye pain and redness was diagnosed with hypertensive anterior uveitis. Following initial management, she was referred to ocular oncology for an atypical clinical picture. Multiple seeds were noted 360 degrees in the anterior chamber, at the equator of the lens and canal of Petit, and ultrasound biomicroscopy identified a temporal pars plana lesion. While aqueous humor cytology was inconclusive for malignancy, targeted next-generation sequencing of aqueous cell-free DNA identified biallelic RB1 full gene deletion, confirming the diagnosis of retinoblastoma. Partial regression followed three cycles of systemic carboplatin, etoposide, and vincristine and three intracameral melphalan injections. Four months later, she had recurrence of the primary tumor and increase in seeding and received the investigational sustained release episcleral topotecan chemoplaque. Stable regression was achieved to 28-month follow-up, with no detectable aqueous cell-free DNA.

Conclusions

RB1 sequencing analysis of tumor-derived cell-free DNA from aqueous humor can confirm the diagnosis of retinoblastoma in cases of diagnostic uncertainty.

Disclosure statement

Dr. Mireskandari is a consultant for Santen Canada Inc., Bayer, and Novartis and has received research funding from Bayer.

Consent for publication

Written consent to publish this case report was obtained from the patient.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.